The Barclays Annual Global Healthcare Conference spotlighted Puma Biotechnology’s advancements in oncology, focusing on innovative cancer treatments. Alan H. Auerbach, Puma’s leader, highlighted the company’s
Tag: Puma Biotechnology
Can Puma Biotechnology Turn the Tables? Discover the Hidden Risks Now
Puma Biotechnology’s Financial Dilemma: An Overview Puma Biotechnology, Inc. (NASDAQ:PBYI) is currently attracting attention due to its remarkably low price-to-sales (P/S) ratio of 0.6x. This